Surgery Partners' historical ROCE trend doesn't indicate potential for future multi-bagger status. Persistent low return on capital from its investments makes it unlikely to be a multi-bagger.
Surgery Partners' high P/S ratio, despite industry-standard revenue forecasts, could risk shareholders' investments and potential investors may pay an unnecessary premium. This may be due to bullish sentiment, which could lead to disappointment if the P/S falls in line with the growth outlook.
Given Surgery Partners' current ROCE trends, it is not seen as a potential high-yield investment. Despite the stock's impressive performance in past years, if current underlying trends continue, the odds of it being a multi-bagger from here is slim.
Surgery Partners Stock Forum
• $Arcos Dorados (ARCO.US)$ : Bradesco BBI Upgrades to Outperform from Neutral - PT $12
• $Armstrong World Industries (AWI.US)$ : Loop Capital Upgrades to Buy from Hold - PT $95
• $Cullen/Frost Bankers (CFR.US)$ : JPMorgan Upgrades to Overweight from Underweight - PT $155 (from $143)
• $Digital Realty Trust Inc (DLR.US)$ : Deutsche Bank Upgrades to Buy from Hold - PT $144 (from $150)
• $Liberty Formula One-A (FWONA.US)$ : Mor...
No comment yet